Table 1 Characteristics of studies included in meta-analysis.
From: Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis
Author, year | Country | Baseline characteristics | No. of participants | Mean age (y) | Male (%) | Follow-up time |
|---|---|---|---|---|---|---|
Abedini, Meinitzer et al.7 | Norway | renal transplant recipients | 2102 | 40.7 | N/A | 6 y (max) |
Aucella, Maas et al.15 | Puglia | haemodialysis and dialysis | 288 | 58 | 57% | 56 m (mean) |
Boeger, Endres et al. 2011 | Germany | Framingham Offspring | 2447 | 73.0 | 43.7% | 5 y (max) |
Boger, Sullivan et al. 2009 | UAS | Framingham Off spring | 3320 | 59 | 45.7% | 10.9 y (mean) |
Borgeraas, Hertel et al.18 | Norway | suspected stable angina pectoris undergoing coronary angiography | 4122 | 62 | 72% | 4.7 y (mean) |
Cavusoglu, Ruwende et al.9 | USA | acute coronary syndrome referred for coronary angiography | 182 | 64.8 | 100% | 2 y (max) |
Cavusoglu, Ruwende et al.11 | USA | diabetes mellitus referred for coronary angiography | 162 | 65.9 | 100% | 2 y (max) |
Frenay, van den Berg et al.19 | Netherlands | Renal transplant recipients | 686 | 53.0 | 57% | 3.1y (mean) |
Gore, Luneburg et al.20 | UK | Dallas Heart Study | 3523 | 43 | 44% | 7.4 y (mean) |
Serbia | dialysis patients | 153 | 58 | 68.6% | 3y (max) | |
hemodialysis | 162 | N/A | N/A | 14 m (N/A) | ||
Koch, Weiskirchen et al.23 | Germany | critically ill patients | 255 | 63(median) | 58.4% | 3y (max) |
Leong, Zylberstein et al.24 | Norway | women in the Population Study (helath) | 880 | N/A | 0% | 24 y (max) |
Levin, Rigatto et al.25 | Canadian | chronic kidney disease | 2544 | 68.1 | 63% | 1y (mean) |
Taiwan | stage 3 to 4 CKD | 298 | 73 | 85.9% | 2.7y (mean) | |
Taiwan | referred for coronary angiography | 997 | 66.9 | 79% | 2.4 y (mean) | |
Mallamaci, Tripepi et al.28 | Italy | end-stage renal disease | 224 | 54.9 | 60 | 42.3 (mean) |
Meinitzer, Kielstein et al.29 | Germany | referred for coronary angiography | 3229 | N/A | N/A | 7.7 y (mean) |
Meinitzer, Seelhorst et al.30 | Germany | angiographic coronary artery disease | 3238 | 62.7 | 69.7% | 5.45 y (mean) |
Mittermayer, Krzyzanowska et al.31 | Austria | advanced peripheral artery disease | 496 | 70 | 56.3% | 19 m (mean) |
Mommersteeg, Schoemaker et al.32 | Netherlands | heart failure | 104 | 65.7 | 72% | 6.1 y (mean) |
Pilz, Putz-Bankuti et al.33 | Austria | chronic liver disease | 94 | 59 | 69.1% | 3.5 y (mean) |
Pizzarelli, Maas et al.34 | Italy | elderly | 1025 | 75 | 44% | 110 m (mean) |
Schulze, Carter et al.13 | UK | acute ischemic stroke | 394 | 69.9 | 53.5% | 7.4 y (mean) |
Schwedhelm, Wallaschofski et al.14 | Germany | study of Health in Pomerania | 3952 | 51 | 49% | 10.1 y (mean) |
Turkey | acute myocardial infarction patients | 168 | 57.4 | 70% | 1 y (max) | |
Siegerink, Maas et al.36 | Germany | stable coronary heart disease | 1148 | 58.7 | 84.6% | 8.1 y (mean) |
Tang, Tong et al.37 | Cleveland | chronic systolic heart failure | 132 | 57.8 | 77% | 33 m (mean) |
Tripepi, Mattace Raso et al.38 | Germany | hemodialysis patients | 225 | 60 | 55% | 13 y (max) |
Young, Terrin et al.39 | USA | stages 3 to 4 chronic kidney disease | 820 | 52 | 60% | 9.5 y (mean) |
Zairis, Patsourakos et al.40 | Greece | chronic heart failure | 651 | 73 | 64.1% | 1 y (max) |
Zeller, Korandji et al.41 | France | acute myocardial infarction | 249 | 68.7 | 78% | 1 y (max) |
Zhang, Blasco-Colmenares et al.42 | USA | heart failure (PROSE-ICD) | 402 | 60.1 | 73.6% | 5.5y (mean) |
heart failure (GRADE) | 240 | 62.5 | 77.1% | 3.7y (mean) | ||
Zoccali, Bode-Boger et al.43 | Germany | hemodialysis patients | 225 | 59.9 | 54.7% | 33.4 m (mean) |
